{"_buckets": {"deposit": "051c7947-9571-4377-9ab3-44a701e33afb"}, "_deposit": {"id": "22527", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "22527"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00022527", "sets": ["456", "1200"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Therapy for Recurrent or Advanced Breast Cancer(The Evolution of Carcinoma of the Mamma)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1990-03", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "178", "bibliographicPageStart": "174", "bibliographicVolumeNumber": "104", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Since advanced breast cancer is a systemic disease, this disease frequently shows hematogenous and multiple metastasis. Therefore, advanced and/or recurrent breast cancer is mainly subjected to systemic treatment, such as endocrine therapy, chemotherapy and immunotherapy, and supplemented with local therapy according to the location of each lesion, such as local resection, arterial infusion and radiotherapy. Multiple agent therapy, employing adriamycin as a main drug, has been widely accepted as chemotherapy at the present time. Internal endocrine therapy with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) has taken the leading role in endocrine therapy. We have also made an attempt to combine chemotherapy with endocrine therapy, chemoendocrine therapy, and/or to use various hormone preparations, multihormone therapy, in expectation of further reinforcement of therapeutic efficacy. Before the initiation of treatment of breast cancer, we should carefully select the most suitable treatment regimen to conditions of individual patients with consideration of the state of ER (PgR), locations and severities of metastasized lesions, previous treatment and a degree of its efficacy, presence or absence of menopause, and performance status.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "136765", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yokomori, Tadahiro"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "横森, 忠紘"}], "nameIdentifiers": [{"nameIdentifier": "136764", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "104(3)_174-178.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "104(3)_174-178.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/22527/files/104(3)_174-178.pdf"}, "version_id": "b76a0ee3-bb1d-4803-91de-6af70f92c183"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "recurrent breast cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chemo-endocrine therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "multihormone therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "再発乳癌", "subitem_subject_scheme": "Other"}, {"subitem_subject": "化学内分泌複合療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "複合内分泌療法", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "5) 再発・進行乳癌の治療(シンポジウム 乳癌をめぐる諸問題, 第448回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "5) 再発・進行乳癌の治療(シンポジウム 乳癌をめぐる諸問題, 第448回新潟医学会)"}, {"subitem_title": "5) 再発・進行乳癌の治療(シンポジウム 乳癌をめぐる諸問題, 第448回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1200"], "permalink_uri": "http://hdl.handle.net/10191/33734", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-10-28"}, "publish_date": "2015-10-28", "publish_status": "0", "recid": "22527", "relation": {}, "relation_version_is_last": true, "title": ["5) 再発・進行乳癌の治療(シンポジウム 乳癌をめぐる諸問題, 第448回新潟医学会)"], "weko_shared_id": null}